Vα14 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes

Biochemical and Biophysical Research Communications

Volumn 378, Issue 3, 2009, Pages 579-583

  Ohtaki, Hirofumi ^a   Ito, Hiroyasu ^a   Ando, Kazuki ^a   Ishikawa, Tetsuya ^b   Saito, Kuniaki ^c   Imawari, Michio ^d   Yokochi, Takashi ^e   Moriwaki, Hisataka ^a   Seishima, Mitsuru ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA KYORITSU HOSPITAL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Galactosylceramide; Intra hepatic lymphocytes; Lipopolysaccharide; Nitric oxide; V 14 NKT cell

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; ALPHA-GALACTOSYLCERAMIDE; CYTOKINE; GALACTOSYLCERAMIDE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; FLOW CYTOMETRY; LIVER CIRCULATION; LYMPHOCYTE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; LIVER; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT;

MURINAE; MUS;

ANIMALS; CYTOKINES; GALACTOSYLCERAMIDES; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; LIVER; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; TOLL-LIKE RECEPTOR 4;

EID: 57749174056     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.11.075     Document Type: Article

References (28)

1. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23 (2005) 877-900
2. Kronenberg M., and Gapin L. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2 (2002) 557-568
3. Taniguchi M., Harada M., Kojo S., Nakayama T., and Wakao H. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21 (2003) 483-513
4. Lorsbach R.B., Murphy W.J., Lowenstein C.J., Snyder S.H., and Russell S.W. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J. Biol. Chem. 268 (1993) 1908-1913
5. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6 (1992) 3051-3064
6. B eckman J.S., and K oppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271 (1996) C1424-C1437
7. Dimmeler S., and Zeiher A.M. Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide 1 (1997) 275-281
8. Kroncke K.D., Fehsel K., and Kolb-Bachofen V. Nitric oxide: cytotoxicity versus cytoprotection-how, why, when, and where?. Nitric Oxide 1 (1997) 107-120
9. Milano S., Arcoleo F., D'Agostino P., and Cillari E. Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood. Antimicrob. Agents Chemother. 41 (1997) 117-121
10. Morikawa A., Kato Y., Sugiyama T., Koide N., Chakravortty D., Yoshida T., and Yokochi T. Role of nitric oxide in lipopolysaccharide-induced hepatic injury in d-galactosamine-sensitized mice as an experimental endotoxic shock model. Infect. Immun. 67 (1999) 1018-1024
11. Genovese T., Cuzzocrea S., Di Paola R., Failla M., Mazzon E., Sortino M.A., Frasca G., Gili E., Crimi N., Caputi A.P., and Vancheri C. Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury. Respir. Res. 6 (2005) 58
12. Beck P.L., Li Y., Wong J., Chen C.W., Keenan C.M., Sharkey K.A., and McCafferty D.M. Inducible nitric oxide synthase from bone marrow-derived cells plays a critical role in regulating colonic inflammation. Gastroenterology 132 (2007) 1778-1790
13. Lu H., Zhu B., and Xue X.D. Role of neuronal nitric oxide synthase and inducible nitric oxide synthase in intestinal injury in neonatal rats. World J. Gastroenterol. 12 (2006) 4364-4368
14. McKim S.E., Gabele E., Isayama F., Lambert J.C., Tucker L.M., Wheeler M.D., Connor H.D., Mason R.P., Doll M.A., Hein D.W., and Arteel G.E. Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Gastroenterology 125 (2003) 1834-1844
15. Menezes J., Hierholzer C., Watkins S.C., Lyons V., Peitzman A.B., Billiar T.R., Tweardy D.J., and Harbrecht B.G. A novel nitric oxide scavenger decreases liver injury and improves survival after hemorrhagic shock. Am. J. Physiol. 277 (1999) G144-G151
16. Sass G., Koerber K., Bang R., Guehring H., and Tiegs G. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J. Clin. Invest. 107 (2001) 439-447
17. Koerber K., Sass G., Kiemer A.K., Vollmar A.M., and Tiegs G. In vivo regulation of inducible no synthase in immune-mediated liver injury in mice. Hepatology 36 (2002) 1061-1069
18. Mabuchi A., Nagao T., Koshio O., Ishiwata T., Yano A., Suzuki K., Yokomuro K., and Wheatley A.M. Role of F4/80Mac-1 adherent non-parenchymal liver cells in concanavalin A-induced hepatic injury in mice. Hepatol. Res. 38 (2008) 1040-1049
19. Guler R., Olleros M.L., Vesin D., Parapanov R., Vesin C., Kantengwa S., Rubbia-Brandt L., Mensi N., Angelillo-Scherrer A., Martinez-Soria E., Tacchini-Cottier F., and Garcia I. Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins. J. Hepatol. 41 (2004) 773-781
20. Ito H., Koide N., Morikawa A., Hassan F., Islam S., Tumurkhuu G., Mori I., Yoshida T., Kakumu S., Moriwaki H., and Yokochi T. Augmentation of lipopolysaccharide-induced nitric oxide production by alpha-galactosylceramide in mouse peritoneal cells. J. Endotoxin Res. 11 (2005) 213-219
21. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126 (1982) 131-138
22. Matuschak G.M., and Rinaldo J.E. Organ interactions in the adult respiratory distress syndrome during sepsis, role of the liver in host defense. Chest 94 (1988) 400-406
23. Baron P., Traber L.D., Traber D.L., Nguyen T., Hollyoak M., Heggers J.P., and Herndon D.N. Gut failure and translocation following burn and sepsis. J. Surg. Res. 57 (1994) 197-204
24. Schmidt H., Secchi A., Wellmann R., Bach A., Bohrer H., Gebhard M.M., and Martin E. Effect of endotoxemia on intestinal villus microcirculation in rats. J. Surg. Res. 61 (1996) 521-526
25. Kitamura H., Iwakabe K., Yahata T., Nishimura S., Ohta A., Ohmi Y., Sato M., Takeda K., Okumura K., Van Kaer L., Kawano T., Taniguchi M., and Nishimura T. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189 (1999) 1121-1128
26. Kitamura H., Ohta A., Sekimoto M., Sato M., Iwakabe K., Nakui M., Yahata T., Meng H., Koda T., Nishimura S., Kawano T., Taniguchi M., and Nishimura T. Alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell. Immunol. 199 (2000) 37-42
27. de Lalla C., Galli G., Aldrighetti L., Romeo R., Mariani M., Monno A., Nuti S., Colombo M., Callea F., Porcelli S.A., Panina-Bordignon P., Abrignani S., Casorati G., and Dellabona P. Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J. Immunol. 173 (2004) 1417-1425
28. Biron C.A., and Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 13 (2001) 458-464